Company: SMNR
Filing Date: 2025-08-08
Form Type: S-4/A
Source: 0001193125-25-177097
Chunk: 583

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-08-08
Form: S-4/A
Chunk 583
---
), less any liabilities outstanding after the Closing. The below summarizes net tangible assets under each redemption scenario.

|                         |     | No         
 Redemption 
 Scenario   |        |   |     | 25%        
 Redemption 
 Scenario   |        |   |     | 50%        
 Redemption 
 Scenario   |        |   |     | 75%        
 Redemption 
 Scenario   |        |   |     | 100%       
 Redemption 
 Scenario   |        |   |
|:------------------------|:----|:-----------|-------:|:--|:----|:-----------|-------:|:--|:----|:-----------|-------:|:--|:----|:-----------|-------:|:--|:----|:-----------|-------:|:--|
| Total Assets            |     | $          |    689 |   |     | $          |    689 |   |     | $          |    689 |   |     | $          |    689 |   |     | $          |    689 |   |
| Less: Total Liabilities |     |            |  3,284 |   |     |            |  3,417 |   |     |            |  3,550 |   |     |            |  3,683 |   |     |            |  3,816 |   |
| Net Tangible Assets     |     | $          | (2,595 | ) |     | $          | (2,728 | ) |     | $          | (2,861 | ) |     | $          | (2,994 | ) |     | $          | (3,127 | ) |

Autonomous Entity Adjustments to Unaudited Pro Forma Condensed Combined Balance Sheet There are no autonomous entity adjustments made to the unaudited pro forma condensed combined balance sheet as of March 31, 2025 as management does not anticipate any net asset impact to be derived from expected contractual arrangements, such as the Transition Services Agreement, to be executed in connection with the closing of the Business Combination. Autonomous Entity Adjustments to Unaudited Pro Forma Condensed Combined Statements of Operations The autonomous entity adjustments included in the unaudited pro forma condensed combined statements of operations for the three months ended March 31, 2025 and the year ended December 31, 2024 reflect adjustments to the estimated incremental portion of the cost of transition services to be provided by Scile